Delivery Order SPE2DB20D1100-SPE2DB24FC3H2
Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a specific pharmaceutical product, 4564482854 CEFAZOLIN 1 G/50 ML-DEXTROSES, for a total ceiling value of $2,339.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Cefpodoxime 200 mg tablets. The contract, valued at $1,096.35, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 21, 2024 with a completion date of June 24, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
- This federal contract award is for a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,162.80, is for the delivery of 4566066569 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a common antibiotic medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed-price delivery order is for the supply of 4566947370 CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,187.46 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564452251 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, which serves as the primary...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,159.96 Firm Fixed Price Delivery Order provides Cefixime 400 mg capsules to the DLA. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,313.65 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564328059 CEFPODOXIME 200 MG TABLET 20S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and...
- This federal contract award, valued at $3,837.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a firm fixed price Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The $1,445.28 award is for the supply of 4565734922 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical pharmaceutical product. The contract has a completion date of September 10, 2024 and does not utilize a set-aside designation. Amerisourcebergen, through its extensive supply...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,218.68 for the supply of 4,566,770,365 units of the drug Cefazolin 2 G/50 ML-Dextroses. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. No set-aside...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FC3H2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564941230 CEFPROZIL 500 MG TABLET 50S to the Defense Logistics Agency (DLA). The contract, valued at $1,053.06, is a Delivery Order with a Firm Fixed Price pricing type. The award falls under DLA's larger Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award does not have a set-aside designation.
Generated 9/20/24, 9:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/18/24 |